International: +1-347-960-6455
Hypotension Therapeutics - Pipeline Analysis 2018

Hypotension Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

Report Code: PP10005 Report Type: Indication Pipeline Reports Available format: 
Therapeutic Area(s): Cardiovascular
Select License Type

Hypotension refers to a low blood pressure condition, which can result in dizziness, fainting or shock. There are several types of hypotension including orthostatic, neutrally mediated, and severe hypotension that are linked to shock. Certain medical conditions like heart problems, anemia, severe infections, endocrine problems, central nervous system disorders, pulmonary embolism, major external or internal bleeding, major loss of body fluids from severe burns, severe swelling of the pancreas, severe diarrhea, severe kidney disease and overuse of diuretics can increase the risk of developing hypotension. Hypotension can be treated by drinking plenty of fluids, eating small low-carbohydrate meals, and several other lifestyles associated modifications. TrioxBio Inc. is in the process of developing MTR-105 for the treatment of hypotension associated with cardiac surgery (vasoplegic syndrome). Some of the other companies involved in the pipeline of the disease are La Jolla Pharmaceutical Company and Theravance Biopharma Inc. among others.

  • The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
  • Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.